The U.S. oncology information systems market was valued at USD 840.3 million in 2023, the market is projected to grow significantly at a CAGR of 7.1% from 2024 to 2030. The growing prevalence of cancer among various demographics and rising demand for advanced innovative oncology information systems are some of the driving factors for the U.S. market. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.

The U.S. accounted for over 31% of the global oncology information systems market in 2023. This region has proven to be competitive and a leading market for novel cancer treatment solutions. It is considered a pioneer in adopting cancer treatment-related devices and solutions. Cancer prevalence is rising in North America, accounting for the second leading cause of death in the U.S. As per the National Cancer Institute, in January 2019, the U.S. had a cancer caseload of 16.9 million and is estimated to reach 22.2 million by 2030.

The presence of nonprofit organizations in the country is boosting R&D efforts to introduce innovative oncology information systems and solutions. Additionally, the penetration and adoption of artificial intelligence in cancer treatment software solutions are estimated to create further growth opportunities in the market. Therefore, due to the increasing adoption of oncology information systems in the region, the rising prevalence of cancers, the increasing number of players, and consistent product innovations, the market is anticipated to grow at a substantial rate during the forecast period.

Curious about the U.S. Oncology Information Systems Market? Get a FREE sample copy of the full report and gain valuable insights.

Key U.S. Oncology Information Systems Company Insights

Some of the prominent U.S. oncology information system companies are Elekta AB, Accuray Incorporated, RaySearch Laboratories, Cerner Corporation, BrainLab, and Philips Healthcare. Launch of new products and mergers & acquisitions are key strategic undertakings of participants in the market.

For instance, in December 2019, ViewRay, Inc. announced its strategic collaboration with Elekta AB and Medtronic. The collaboration with Elekta is aimed at advancing the utilization and knowledge of MR-guided radiation therapy. Such collaborations are expected to help in creating strong commercial relations with other key players in the market, thereby strengthening the player’s foothold.

Key U.S. Oncology Information System Companies:

• Elekta AB

• Accuray Incorporated

• Varian Medical Systems (Siemens Healthineers)

• RaySearch Laboratories

• Cerner Corporation (Oracle Corporation)

• BrainLab

• Philips Healthcare

• Prowess, Inc.

• DOSIsoft S.A.

• ViewRay Inc.

• MIM Software and Flatiron

Recent Developments

• In May 2022, RaySearch Laboratories collaborated with GE Healthcare to codevelop an advanced radiation therapy simulation and incorporate the latest advancements made in the field of treatment planning systems technology. Under this collaboration, RaySearch would integrate GE Healthcare’s multi-modality simulator in its RayStation treatment planning system.

• In June 2022, Accuray Incorporated and Limbus AI Inc. entered a strategic partnership to amalgamate Limbus’ AI-powered auto-contouring algorithms with Accuray’s adaptive radiotherapy capabilities. The two companies would focus on enhancing treatment planning process software solutions as part of the agreement.

U.S. Oncology Information Systems Market Report Segmentation

Grand View Research, Inc. has segmented the U.S. oncology information systems market on the basis of product and services, and application:

Products And Services Outlook (Revenue, USD Million, 2018 - 2030)

• Software

o Patient Information Systems

o Treatment Planning Systems

• Professional Services

Application Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Oncology

• Radiation Oncology

• Surgical Oncology

Order a free sample PDF of the U.S. Oncology Information Systems Market Intelligence Study, published by Grand View Research.